ENDRA Life Sciences Inc. Stock News

ENDRA Life Sciences (NASDAQ:NDRA) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a research note issued on Saturday, Zacks.com reports. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. NASDAQ NDRA []

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Tips For Effortless money: Ardelyx, Inc. (NASDAQ:ARDX 12.86%), ENDRA Life Sciences Inc. (NASDAQ:NDRA -4.84%) appeared first on Stocks Equity .

In the last trading session, 1.15 million ENDRA Life Sciences Inc. (NASDAQ:NDRA) shares changed hands as the company’s beta touched 1.24. With the company’s per share price at $0.87 changed hands at $0.07 or 8.31% during last session, the market valuation stood at $38.53M. NDRA’s last price was a discount, traded about -256.32% off its … ENDRA Life Sciences Inc. (NASDAQ: NDRA): Don’t Ditch NDRA Stock In 2021 Read More »

Zacks Investment Research upgraded shares of ENDRA Life Sciences (NASDAQ:NDRA) from a hold rating to a buy rating in a report issued on Monday morning, Zacks.com reports. They currently have $1.00 target price on the stock. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is []

ANN ARBOR, Mich. & SYDNEY--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), and VGI Health Technology Limited (NSX: VTL), a clinical-stage biotechnology company specializing in developing and commercializing evidence-based nutraceuticals and pharmaceuticals, announce today the signing of a collaboration agreement to incorporate ENDRAs proprietary TAEUS technology to support patient screening and biomarker measurement during VG

ADM Tronics Unlimited (OTCMKTS:ADMT) and ENDRA Life Sciences (NASDAQ:NDRA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk. Earnings & Valuation This table compares ADM Tronics Unlimited and ENDRA Life Sciences []

ENDRA Life Sciences (NASDAQ:NDRA) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. Shares of []

Zacks Investment Research downgraded shares of ENDRA Life Sciences (NASDAQ:NDRA) from a buy rating to a hold rating in a report published on Wednesday, Zacks.com reports. According to Zacks, “ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. “ Shares of NDRA […]

Citius Pharmaceuticals, Inc. (CTXR) with the stream of -2.05% also noticed, India ENDRA Life Sciences Inc. (NDRA) encountered a rapid change of -9.11% in the last hour of Monday’s trading … The post Up to Date Stock in Review: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), ENDRA Life Sciences Inc. (NASDAQ:NDRA) appeared first on Stocks Equity .

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis Treatment Candidate Keza

ENDRA Life Sciences Inc. (NDRA) delivered earnings and revenue surprises of 14.29% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for th

ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q3 2021 Results - Earnings Call Transcript

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months ended September 30, 2021 and provided a business update. Highlights of the third quarter of 2021 and recent weeks include: Patient screening was initiated at the University of Pittsburgh Medical Center (UPMC) while it continues to work through a pandemic-related backlog of MRI procedures. Both the UPM

ENDRA Life Sciences Inc. (NDRA) delivered earnings and revenue surprises of 14.29% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for th